MedTrace Logo

Evaluation of Treatment Factors in the Management of Chronic Iliotibial Band Syndrome in Female Distance Runners

NCT02296151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-03-27

No results posted yet for this study

Summary

The primary objective of this study is to determine if a more specific exercise routine that incorporates a progressive hip stability program will help to rehabilitate the hip and reduce symptoms of iliotibial band syndrome more than conventional hip exercises. Three different exercises interventions will be compared to determine its effectiveness in reducing pain, improving function and returning subjects to running symptom free. Secondary objective for this study is to establish an intervention program for female runners with this injury. There will be three treatment arms and participants will be randomly assigned to one of three groups: Group A- control (stretching), group B (conventional hip exercises and group C (experimental treatment- specific progressive hip exercises).

Conditions

  • Iliotibial Band Syndrome

Interventions

OTHER

Gluteus medius strengthening

Hip abductor, gluteus medius strengthening

OTHER

iliotibial band stretches

Iliotibial band stretches

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Dr. Rick Celebrini, PhD, PT · Chief sport officer- Fortius sport & health

  • Dr. Michael Hunt, MSc MPT PhD · Assistant Professor (UBC)- Department of Physical Therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02296151 on ClinicalTrials.gov